Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
62 participants
INTERVENTIONAL
2023-12-21
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FLO2 for Recovery After SCI
NCT03833674
Hypoxia Pathways for Early Recovery After Spinal Cord Injury
NCT07002437
Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury
NCT03071393
Effects of Breathing and Walking Treatments on Recovery Post-Spinal Cord Injury
NCT01272011
Acute Intermittent Hypoxia on Leg Function Following Spinal Cord Injury
NCT02274116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On single-session testing days, participants will be asked to come in on three separate days they will complete a battery of tests, then be given one of three interventions, and then complete the same battery of tests. The three interventions are acute intermittent hypoxia (AIH), acute intermittent hypercapnic-hypoxia (AIHH), or sham acute intermittent hypoxia (sham AIH). These interventions are explained in more detail below.
During respiratory strength training blocks, participants will receive five days of AIH, AIHH, or sham AIH in combination with respiratory strength training, which uses small hand-held devices to strengthen the muscles used for breathing. Participants will be asked to complete all three blocks to receive all three interventions. In addition to 5 days of interventions and respiratory strength training, the respiratory strength training blocks include testing 1 day, 3 days, and 7 days after the 5 days of respiratory strength training.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single-session testing days
Participants will complete three separate single-session testing days. Baseline testing will be performed, then on each day, participants will receive AIH, AIHH, and sham AIH in random order. Post-testing will occur after each intervention.
Acute Intermittent Hypoxia (AIH)
AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).
Acute Intermittent Hypercapnic-Hypoxia (AIHH)
AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).
Sham AIH
A single session of sham AIH with episodes of normal room air (21% O2).
Respiratory strength training blocks
Participants will complete three separate respiratory strength training blocks. In each block, participants will receive 5 days of AIH, 5 days of AIHH, and 5 days of sham AIH in random order, followed by respiratory strength training. Each block will include 5 days of intervention and training, and post-testing 1, 3, and 7 days after intervention and training has concluded.
Acute Intermittent Hypoxia (AIH)
AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).
Acute Intermittent Hypercapnic-Hypoxia (AIHH)
AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).
Sham AIH
A single session of sham AIH with episodes of normal room air (21% O2).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acute Intermittent Hypoxia (AIH)
AIH (acute intermittent hypoxia) consists of short episodes of low oxygen (9% O2).
Acute Intermittent Hypercapnic-Hypoxia (AIHH)
AIHH consists of short episodes of low oxygen (9% O2) and elevated carbon dioxide (4% CO2).
Sham AIH
A single session of sham AIH with episodes of normal room air (21% O2).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Chronic incomplete SCI ≥ 1 year at or below C1-T12
* Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
-OR- Chronic complete SCI ≥1 year at or below C4-T12
* Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
3. Medically stable with physician clearance
4. SCI due to non-progressive etiology
5. 20% impairment in maximal inspiratory, maximal expiratory pressure generation, or both relative to normative values
Exclusion Criteria
2. Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension
3. Severe neuropathic pain
4. Known pregnancy
5. Severe recurrent autonomic dysreflexia
Exclusion for involvement in TMS - History of seizure disorder, uncontrolled migraines, presence of cardiac pacemaker, metal implants in skull, medications that lower seizure threshold.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Army Medical Research Acquisition Activity
FED
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Fox, DPT, MHS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Florida & Brooks Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brooks Rehabilitation
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W81XWH2210478
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB202202891
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.